Filing Flows › Companies › GE HealthCare Technologies › Timeline
GE HealthCare Technologies stock timeline
A year of the price with every insider trade, planned sale, earnings report and material 8-K marked
252 sessions+11.2% to $82.38
GE HealthCare Technologies (GEHC) stock rose 11% over the last 252 sessions, to $82.38. On the way it reported 4 quarters, its insiders filed no open-market trades (10b5-1 plan sales aside) and 1 Form 144 notice of planned sales, and the company filed 8 material 8-Ks. Each is marked on the price and listed with what the stock did next.
Each mark, and what followed
| Date | Kind | What | Next session | 5 sessions | 21 sessions |
|---|---|---|---|---|---|
| Nov 5, 2026 | 8-K | Directors and officers: departures, appointments, pay | −2.4% (+2.1% vs SPY) | — | — |
| Nov 4, 2026 | Form 144 | Form 144: James Saccaro plans to sell $6.7M | +6.2% (+4.6% vs SPY) | — | — |
| Oct 28, 2026 | 8-K | Directors and officers: departures, appointments, pay | +6.4% (+6.1% vs SPY) | +12.6% (+14.6% vs SPY) | — |
| Oct 28, 2026 | Earnings | Earnings: beat the EPS estimate by 11.3% | +6.4% (+6.1% vs SPY) | +12.6% (+14.6% vs SPY) | — |
| Sep 22, 2026 | 8-K | Directors and officers: departures, appointments, pay | −0.3% (+0.5% vs SPY) | +0.3% (+1.5% vs SPY) | +4.1% (+4.1% vs SPY) |
| Aug 18, 2026 | 8-K | Directors and officers: departures, appointments, pay | +0.4% (+1.0% vs SPY) | +2.5% (+3.7% vs SPY) | −13.1% (−10.6% vs SPY) |
| Jul 29, 2026 | Earnings | Earnings: beat the EPS estimate by 9.1% | +11.5% (+13.0% vs SPY) | +9.2% (+5.1% vs SPY) | +13.4% (+10.0% vs SPY) |
| Jul 23, 2026 | 8-K | Directors and officers: departures, appointments, pay | −2.2% (−2.3% vs SPY) | +12.1% (+11.7% vs SPY) | +18.9% (+15.2% vs SPY) |
| Apr 29, 2026 | Earnings | Earnings: missed the EPS estimate by -5.7% | −14.1% (−14.1% vs SPY) | −11.5% (−13.2% vs SPY) | −8.6% (−14.5% vs SPY) |
| Mar 17, 2026 | 8-K | Directors and officers: departures, appointments, pay | +0.2% (0.0% vs SPY) | −0.7% (+1.1% vs SPY) | +1.9% (−2.9% vs SPY) |
| Feb 27, 2026 | 8-K | Material definitive agreement | −5.0% (−5.1% vs SPY) | −12.6% (−10.6% vs SPY) | −20.3% (−12.4% vs SPY) |
| Feb 4, 2026 | Earnings | Earnings: beat the EPS estimate by 3.0% | +4.8% (+5.3% vs SPY) | +0.6% (+0.2% vs SPY) | −2.2% (−0.9% vs SPY) |
| Dec 15, 2025 | 8-K | Material definitive agreement | −2.6% (−2.4% vs SPY) | −0.6% (−1.5% vs SPY) | −2.3% (−4.2% vs SPY) |
What this kind of 8-K usually did
| Item | 8-Ks | Next session, median | Up next session | 21 sessions, median | Typical size |
|---|---|---|---|---|---|
| 1.01 Material definitive agreement | 23,525 | 0.0% | 51% | +1.0% | ±1.4% |
| 2.03 New debt or off-balance-sheet obligation | 13,268 | 0.0% | 50% | +1.2% | ±1.3% |
| 1.02 Termination of a material agreement | 2,368 | 0.0% | 51% | +1.1% | ±1.5% |
| 5.02 Directors and officers: departures, appointments, pay | 39,174 | −0.1% | 48% | +0.7% | ±1.4% |
Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →
Report card: every quarter against the estimate → GE HealthCare Technologies: every quarter → Live insider trades →
Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.